BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -70.82 Million USD | -44.15% |
| 2022 | -39.91 Million USD | -31.44% |
| 2021 | -30.36 Million USD | -811.34% |
| 2020 | -3.33 Million USD | -326.63% |
| 2019 | -781 Thousand USD | -121.33% |
| 2018 | 3.66 Million USD | 446.78% |
| 2017 | -1.05 Million USD | 78.23% |
| 2016 | -4.85 Million USD | 3.31% |
| 2015 | -5.01 Million USD | -60.0% |
| 2014 | -3.13 Million USD | -998.87% |
| 2013 | -285.35 Thousand USD | 69.71% |
| 2012 | -942.23 Thousand USD | 22.11% |
| 2011 | -1.2 Million USD | 13.23% |
| 2010 | -1.39 Million USD | 39.05% |
| 2009 | -2.28 Million USD | 7.15% |
| 2008 | -2.46 Million USD | 9.21% |
| 2007 | -2.71 Million USD | -81.58% |
| 2006 | -1.49 Million USD | -138.13% |
| 2005 | -627.53 Thousand USD | 4.69% |
| 2004 | -658.42 Thousand USD | 58.77% |
| 2003 | -1.59 Million USD | -157.56% |
| 2002 | -620.11 Thousand USD | 85.91% |
| 2001 | -4.4 Million USD | -53.33% |
| 2000 | -2.87 Million USD | -150.68% |
| 1999 | -1.14 Million USD | 7.93% |
| 1998 | -1.24 Million USD | 24.95% |
| 1997 | -1.65 Million USD | 0.0% |
| 1996 | - USD | 100.0% |
| 1995 | -1.81 Million USD | 13.74% |
| 1994 | -2.1 Million USD | 69.12% |
| 1993 | -6.8 Million USD | -44.68% |
| 1992 | -4.7 Million USD | -88.0% |
| 1991 | -2.5 Million USD | -66.67% |
| 1990 | -1.5 Million USD | -400.0% |
| 1989 | -300 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.89 Million USD | 27.11% |
| 2024 Q2 | -2.79 Million USD | 71.74% |
| 2023 Q1 | -12.88 Million USD | -26.19% |
| 2023 FY | -57.53 Million USD | -44.15% |
| 2023 Q2 | -15.28 Million USD | -18.59% |
| 2023 Q4 | -13.57 Million USD | 52.85% |
| 2023 Q3 | -28.78 Million USD | -88.37% |
| 2022 FY | -39.91 Million USD | -31.44% |
| 2022 Q1 | -10.95 Million USD | 39.74% |
| 2022 Q2 | -8.71 Million USD | 20.43% |
| 2022 Q3 | -9.05 Million USD | -3.9% |
| 2022 Q4 | -10.21 Million USD | -12.73% |
| 2021 FY | -30.36 Million USD | -811.34% |
| 2021 Q3 | -11.15 Million USD | -144.98% |
| 2021 Q2 | -4.55 Million USD | -364.32% |
| 2021 Q4 | -18.18 Million USD | -62.95% |
| 2021 Q1 | -981 Thousand USD | 79.28% |
| 2020 Q1 | 370 Thousand USD | 132.2% |
| 2020 Q3 | -1.24 Million USD | -2931.82% |
| 2020 Q4 | -4.73 Million USD | -280.02% |
| 2020 FY | -3.33 Million USD | -326.63% |
| 2020 Q2 | 44 Thousand USD | -88.11% |
| 2019 Q4 | -1.14 Million USD | -92.46% |
| 2019 Q1 | 491 Thousand USD | -52.92% |
| 2019 Q2 | 919 Thousand USD | 87.17% |
| 2019 FY | -781 Thousand USD | -121.33% |
| 2019 Q3 | -597 Thousand USD | -164.96% |
| 2018 Q1 | 139.72 Thousand USD | 164.09% |
| 2018 FY | 3.66 Million USD | 446.78% |
| 2018 Q4 | 1.04 Million USD | -12.72% |
| 2018 Q3 | 1.19 Million USD | -6.99% |
| 2018 Q2 | 1.28 Million USD | 819.53% |
| 2017 Q1 | -464.03 Thousand USD | 25.99% |
| 2017 Q2 | -341.2 Thousand USD | 26.47% |
| 2017 FY | -1.05 Million USD | 78.23% |
| 2017 Q4 | -218 Thousand USD | -573.98% |
| 2017 Q3 | -32.34 Thousand USD | 90.52% |
| 2016 Q3 | -1.13 Million USD | 28.61% |
| 2016 Q2 | -1.59 Million USD | -6.8% |
| 2016 Q1 | -1.49 Million USD | -6.28% |
| 2016 FY | -4.85 Million USD | 3.31% |
| 2016 Q4 | -627 Thousand USD | 44.9% |
| 2015 Q3 | -1.29 Million USD | -12.16% |
| 2015 Q2 | -1.15 Million USD | 0.4% |
| 2015 Q4 | -1.4 Million USD | -8.32% |
| 2015 FY | -5.01 Million USD | -60.0% |
| 2015 Q1 | -1.16 Million USD | -15.56% |
| 2014 FY | -3.13 Million USD | -998.87% |
| 2014 Q4 | -1 Million USD | -14.84% |
| 2014 Q3 | -874.51 Thousand USD | 1.5% |
| 2014 Q2 | -887.87 Thousand USD | -140.59% |
| 2014 Q1 | -369.04 Thousand USD | -29.6% |
| 2013 Q2 | -82.84 Thousand USD | -143.07% |
| 2013 Q3 | -110.09 Thousand USD | -32.89% |
| 2013 Q4 | -284.75 Thousand USD | -158.65% |
| 2013 FY | -285.35 Thousand USD | 69.71% |
| 2013 Q1 | 192.33 Thousand USD | 162.52% |
| 2012 Q4 | -307.63 Thousand USD | -106.87% |
| 2012 Q3 | -148.7 Thousand USD | 51.5% |
| 2012 Q1 | -179.26 Thousand USD | 14.87% |
| 2012 Q2 | -306.63 Thousand USD | -71.05% |
| 2012 FY | -942.23 Thousand USD | 22.11% |
| 2011 Q4 | -210.58 Thousand USD | 26.06% |
| 2011 Q2 | -260.01 Thousand USD | 42.76% |
| 2011 Q1 | -454.27 Thousand USD | -44.07% |
| 2011 Q3 | -284.8 Thousand USD | -9.54% |
| 2011 FY | -1.2 Million USD | 13.23% |
| 2010 FY | -1.39 Million USD | 39.05% |
| 2010 Q4 | -315.31 Thousand USD | -10.18% |
| 2010 Q3 | -286.19 Thousand USD | 26.9% |
| 2010 Q2 | -391.52 Thousand USD | 0.58% |
| 2010 Q1 | -393.81 Thousand USD | -70.96% |
| 2009 Q1 | -733.39 Thousand USD | -1.91% |
| 2009 Q3 | -432.88 Thousand USD | 51.51% |
| 2009 Q2 | -892.73 Thousand USD | -21.73% |
| 2009 Q4 | -230.35 Thousand USD | 46.79% |
| 2009 FY | -2.28 Million USD | 7.15% |
| 2008 FY | -2.46 Million USD | 9.21% |
| 2008 Q2 | -594.69 Thousand USD | -6.08% |
| 2008 Q4 | -719.65 Thousand USD | -22.29% |
| 2008 Q1 | -560.61 Thousand USD | 15.3% |
| 2008 Q3 | -588.49 Thousand USD | 1.04% |
| 2007 Q3 | -728.98 Thousand USD | 1.11% |
| 2007 Q1 | -585.39 Thousand USD | -31.95% |
| 2007 Q2 | -737.2 Thousand USD | -25.93% |
| 2007 Q4 | -661.91 Thousand USD | 9.2% |
| 2007 FY | -2.71 Million USD | -81.58% |
| 2006 Q3 | -395.76 Thousand USD | 11.23% |
| 2006 Q4 | -443.65 Thousand USD | -12.1% |
| 2006 FY | -1.49 Million USD | -138.13% |
| 2006 Q1 | -209.12 Thousand USD | -20.71% |
| 2006 Q2 | -445.81 Thousand USD | -113.18% |
| 2005 Q1 | -165.55 Thousand USD | -9364.63% |
| 2005 Q2 | -189.52 Thousand USD | -14.48% |
| 2005 Q3 | -157.92 Thousand USD | 16.67% |
| 2005 Q4 | -173.23 Thousand USD | -9.7% |
| 2005 FY | -627.53 Thousand USD | 4.69% |
| 2004 Q2 | -237.57 Thousand USD | 11.74% |
| 2004 FY | -658.42 Thousand USD | 58.77% |
| 2004 Q4 | 1787.00 USD | 101.16% |
| 2004 Q3 | -153.46 Thousand USD | 35.41% |
| 2004 Q1 | -269.17 Thousand USD | -23.26% |
| 2003 Q4 | -218.36 Thousand USD | 60.5% |
| 2003 FY | -1.59 Million USD | -157.56% |
| 2003 Q1 | -330.42 Thousand USD | -33.03% |
| 2003 Q2 | -481.2 Thousand USD | -45.63% |
| 2003 Q3 | -552.81 Thousand USD | -14.88% |
| 2002 FY | -620.11 Thousand USD | 85.91% |
| 2002 Q1 | -382.3 Thousand USD | 53.17% |
| 2002 Q3 | -210.07 Thousand USD | 36.41% |
| 2002 Q2 | -330.35 Thousand USD | 13.59% |
| 2002 Q4 | -248.38 Thousand USD | -18.24% |
| 2001 Q1 | -1.09 Million USD | 0.35% |
| 2001 FY | -4.4 Million USD | -53.33% |
| 2001 Q4 | -816.28 Thousand USD | 28.03% |
| 2001 Q3 | -1.13 Million USD | 16.33% |
| 2001 Q2 | -1.35 Million USD | -23.87% |
| 2000 Q1 | -149 Thousand USD | 75.17% |
| 2000 Q4 | -1.09 Million USD | -50.85% |
| 2000 Q3 | -728.02 Thousand USD | 18.63% |
| 2000 Q2 | -894.7 Thousand USD | -500.44% |
| 2000 FY | -2.87 Million USD | -150.68% |
| 1999 Q1 | -320 Thousand USD | 27.85% |
| 1999 Q3 | -200 Thousand USD | -100.0% |
| 1999 Q4 | -600 Thousand USD | -200.0% |
| 1999 FY | -1.14 Million USD | 7.93% |
| 1999 Q2 | -100 Thousand USD | 68.75% |
| 1998 Q4 | -443.52 Thousand USD | 0.0% |
| 1998 Q1 | -400 Thousand USD | 28.19% |
| 1998 Q2 | -100 Thousand USD | 75.0% |
| 1998 Q3 | - USD | 100.0% |
| 1998 FY | -1.24 Million USD | 24.95% |
| 1997 FY | -1.65 Million USD | 0.0% |
| 1997 Q1 | -100 Thousand USD | 0.0% |
| 1997 Q3 | -100 Thousand USD | 83.33% |
| 1997 Q4 | -557 Thousand USD | -457.01% |
| 1997 Q2 | -600 Thousand USD | -500.0% |
| 1996 Q3 | -100 Thousand USD | 94.78% |
| 1996 Q1 | -100 Thousand USD | 75.0% |
| 1996 Q2 | -1.91 Million USD | -1814.45% |
| 1996 FY | - USD | 100.0% |
| 1995 Q3 | -200 Thousand USD | 51.4% |
| 1995 FY | -1.81 Million USD | 13.74% |
| 1995 Q1 | -700 Thousand USD | -115.22% |
| 1995 Q4 | -400 Thousand USD | -100.0% |
| 1995 Q2 | -411.53 Thousand USD | 41.21% |
| 1994 Q2 | -200 Thousand USD | 81.82% |
| 1994 Q3 | -300 Thousand USD | -50.0% |
| 1994 Q1 | -1.1 Million USD | -266.67% |
| 1994 FY | -2.1 Million USD | 69.12% |
| 1994 Q4 | 4.6 Million USD | 1633.33% |
| 1993 FY | -6.8 Million USD | -44.68% |
| 1993 Q4 | -300 Thousand USD | 25.0% |
| 1993 Q3 | -400 Thousand USD | 75.0% |
| 1993 Q2 | -1.6 Million USD | -23.08% |
| 1993 Q1 | -1.3 Million USD | 35.0% |
| 1992 Q2 | -5.1 Million USD | -5200.0% |
| 1992 FY | -4.7 Million USD | -88.0% |
| 1992 Q4 | -2 Million USD | -11.11% |
| 1992 Q3 | -1.8 Million USD | 64.71% |
| 1992 Q1 | 100 Thousand USD | 107.69% |
| 1991 Q4 | -1.3 Million USD | -1400.0% |
| 1991 FY | -2.5 Million USD | -66.67% |
| 1991 Q2 | -2.8 Million USD | -2900.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 103.57% |
| 1990 Q3 | -800 Thousand USD | 55.56% |
| 1990 Q4 | 100 Thousand USD | 112.5% |
| 1990 Q1 | 100 Thousand USD | 0.0% |
| 1990 FY | -1.5 Million USD | -400.0% |
| 1990 Q2 | -1.8 Million USD | -1900.0% |
| 1989 Q1 | 100 Thousand USD | 0.0% |
| 1989 FY | -300 Thousand USD | 0.0% |
| 1989 Q4 | 100 Thousand USD | 0.0% |
| 1989 Q3 | 100 Thousand USD | 125.0% |
| 1989 Q2 | -400 Thousand USD | -500.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | -22.815% |
| AngioDynamics, Inc. | -97.71 Million USD | 27.521% |
| AtriCure, Inc. | -26.68 Million USD | -165.431% |
| Avinger, Inc. | -16.63 Million USD | -325.759% |
| Azenta, Inc. | -73.12 Million USD | 3.147% |
| The Cooper Companies, Inc. | 533.1 Million USD | 113.285% |
| Daxor Corporation | -177.07 Thousand USD | -39897.176% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | -368.667% |
| Femasys Inc. | -14.5 Million USD | -388.165% |
| GlucoTrack, Inc. | -7.1 Million USD | -896.974% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 3839.44% |
| Hologic, Inc. | 882.6 Million USD | 108.025% |
| ICU Medical, Inc. | 22.82 Million USD | 410.296% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 104.009% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -589.631% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 290.996% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -926.369% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -926.369% |
| Masimo Corporation | 136.5 Million USD | 151.886% |
| Microbot Medical Inc. | -9.85 Million USD | -618.671% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 582.626% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 157.143% |
| Nephros, Inc. | -1.59 Million USD | -4346.014% |
| NovoCure Limited | -232.87 Million USD | 69.586% |
| NEXGEL, Inc. | -3.47 Million USD | -1936.957% |
| NEXGEL, Inc. | -3.47 Million USD | -1936.957% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 31.105% |
| OraSure Technologies, Inc. | 54.07 Million USD | 230.966% |
| Pro-Dex, Inc. | 7.17 Million USD | 1087.383% |
| Pulse Biosciences, Inc. | -43.57 Million USD | -62.54% |
| Predictive Oncology Inc. | -13.92 Million USD | -408.752% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -2499.719% |
| QuidelOrtho Corporation | 139.1 Million USD | 150.917% |
| Repligen Corporation | 54.57 Million USD | 229.773% |
| Sanara MedTech Inc. | -4.21 Million USD | -1580.247% |
| STAAR Surgical Company | 28.09 Million USD | 352.073% |
| Sharps Technology, Inc. | -10.12 Million USD | -599.392% |
| Utah Medical Products, Inc. | 16.77 Million USD | 522.155% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 16.676% |
| Jin Medical International Ltd. | 2.86 Million USD | 2570.127% |